Creative Biolabs-Immuno-oncology

Anti-FGFR2 (clone FR2E-1G4I) SynExpress C-Cy3-P-P Modified CD8+ T cells (CAT#: ITS-1224-CR705)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FGFR2 (clone FR2E-1G4I). We employs the HBV (CMV-Cy3-PAX-PstI) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
FGFR2
Clone
FR2E-1G4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
PAX
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving